Human Immunodeficiency Virus -1 Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
1.2.4 Entry and Fusion Inhibitors
1.2.5 Protease Inhibitors (PIs)
1.2.6 Integrase Inhibitors
1.2.7 Coreceptor Antagonists
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Labs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Perspective (2017-2028)
2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Growth Trends by Region
2.2.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Dynamics
2.3.1 Human Immunodeficiency Virus (HIV)-1 Therapeutics Industry Trends
2.3.2 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Drivers
2.3.3 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Challenges
2.3.4 Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue
3.4 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in 2021
3.5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus (HIV)-1 Therapeutics Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Type (2023-2028)
5 Human Immunodeficiency Virus (HIV)-1 Therapeutics Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2017-2028)
6.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
6.2.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2017-2028)
6.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
6.3.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2017-2028)
6.4 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
6.4.1 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2017-2028)
7.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2017-2028)
7.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2017-2028)
7.4 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2017-2028)
9.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
9.2.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
9.3.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
9.4.1 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie, Inc.(U.S.)
11.1.1 AbbVie, Inc.(U.S.) Company Details
11.1.2 AbbVie, Inc.(U.S.) Business Overview
11.1.3 AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.1.4 AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.1.5 AbbVie, Inc.(U.S.) Recent Developments
11.2 Merck & Co., Inc. (U.S.)
11.2.1 Merck & Co., Inc. (U.S.) Company Details
11.2.2 Merck & Co., Inc. (U.S.) Business Overview
11.2.3 Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.2.4 Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.2.5 Merck & Co., Inc. (U.S.) Recent Developments
11.3 Bristol-Myers Squibb Company (U.S.)
11.3.1 Bristol-Myers Squibb Company (U.S.) Company Details
11.3.2 Bristol-Myers Squibb Company (U.S.) Business Overview
11.3.3 Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.3.5 Bristol-Myers Squibb Company (U.S.) Recent Developments
11.4 Boehringer Ingelheim GmbH (Germany)
11.4.1 Boehringer Ingelheim GmbH (Germany) Company Details
11.4.2 Boehringer Ingelheim GmbH (Germany) Business Overview
11.4.3 Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.4.4 Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.4.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
11.5 Genentech, Inc. (U.S.)
11.5.1 Genentech, Inc. (U.S.) Company Details
11.5.2 Genentech, Inc. (U.S.) Business Overview
11.5.3 Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.5.4 Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.5.5 Genentech, Inc. (U.S.) Recent Developments
11.6 Cipla, Inc. (India)
11.6.1 Cipla, Inc. (India) Company Details
11.6.2 Cipla, Inc. (India) Business Overview
11.6.3 Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Introduction
11.6.4 Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
11.6.5 Cipla, Inc. (India) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Key Players of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Table 4. Key Players of Entry and Fusion Inhibitors
Table 5. Key Players of Protease Inhibitors (PIs)
Table 6. Key Players of Integrase Inhibitors
Table 7. Key Players of Coreceptor Antagonists
Table 8. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Region (2017-2022)
Table 12. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Region (2023-2028)
Table 14. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Trends
Table 15. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Drivers
Table 16. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Challenges
Table 17. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Restraints
Table 18. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Share by Players (2017-2022)
Table 20. Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics as of 2021)
Table 21. Ranking of Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Human Immunodeficiency Virus (HIV)-1 Therapeutics Product Solution and Service
Table 25. Date of Enter into Human Immunodeficiency Virus (HIV)-1 Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2017-2022)
Table 29. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Market Share by Type (2023-2028)
Table 31. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Share by Application (2017-2022)
Table 33. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue Share by Application (2023-2028)
Table 35. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 36. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 37. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 38. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 39. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 42. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 43. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 44. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 45. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 46. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 47. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 48. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 49. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 50. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 51. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 52. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 53. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 54. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 55. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 56. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 57. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 58. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 65. AbbVie, Inc.(U.S.) Company Details
Table 66. AbbVie, Inc.(U.S.) Business Overview
Table 67. AbbVie, Inc.(U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 68. AbbVie, Inc.(U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 69. AbbVie, Inc.(U.S.) Recent Developments
Table 70. Merck & Co., Inc. (U.S.) Company Details
Table 71. Merck & Co., Inc. (U.S.) Business Overview
Table 72. Merck & Co., Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 73. Merck & Co., Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 74. Merck & Co., Inc. (U.S.) Recent Developments
Table 75. Bristol-Myers Squibb Company (U.S.) Company Details
Table 76. Bristol-Myers Squibb Company (U.S.) Business Overview
Table 77. Bristol-Myers Squibb Company (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 78. Bristol-Myers Squibb Company (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Bristol-Myers Squibb Company (U.S.) Recent Developments
Table 80. Boehringer Ingelheim GmbH (Germany) Company Details
Table 81. Boehringer Ingelheim GmbH (Germany) Business Overview
Table 82. Boehringer Ingelheim GmbH (Germany) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 83. Boehringer Ingelheim GmbH (Germany) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Boehringer Ingelheim GmbH (Germany) Recent Developments
Table 85. Genentech, Inc. (U.S.) Company Details
Table 86. Genentech, Inc. (U.S.) Business Overview
Table 87. Genentech, Inc. (U.S.) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 88. Genentech, Inc. (U.S.) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 89. Genentech, Inc. (U.S.) Recent Developments
Table 90. Cipla, Inc. (India) Company Details
Table 91. Cipla, Inc. (India) Business Overview
Table 92. Cipla, Inc. (India) Human Immunodeficiency Virus (HIV)-1 Therapeutics Product
Table 93. Cipla, Inc. (India) Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Cipla, Inc. (India) Recent Developments
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Features
Figure 3. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Features
Figure 4. Entry and Fusion Inhibitors Features
Figure 5. Protease Inhibitors (PIs) Features
Figure 6. Integrase Inhibitors Features
Figure 7. Coreceptor Antagonists Features
Figure 8. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Application: 2021 VS 2028
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Labs Case Studies
Figure 12. Human Immunodeficiency Virus (HIV)-1 Therapeutics Report Years Considered
Figure 13. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Region: 2021 VS 2028
Figure 16. Global Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Share by Players in 2021
Figure 17. Global Top Human Immunodeficiency Virus (HIV)-1 Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus (HIV)-1 Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus (HIV)-1 Therapeutics Revenue in 2021
Figure 19. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2028)
Figure 21. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2028)
Figure 22. North America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Country (2017-2028)
Figure 23. United States Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Country (2017-2028)
Figure 29. Germany Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Region (2017-2028)
Figure 39. China Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Country (2017-2028)
Figure 49. Mexico Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size Share by Country (2017-2028)
Figure 55. Turkey Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Human Immunodeficiency Virus (HIV)-1 Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. AbbVie, Inc.(U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 59. Merck & Co., Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 60. Bristol-Myers Squibb Company (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 61. Boehringer Ingelheim GmbH (Germany) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 62. Genentech, Inc. (U.S.) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 63. Cipla, Inc. (India) Revenue Growth Rate in Human Immunodeficiency Virus (HIV)-1 Therapeutics Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Industry Market Size
